Vanguard Group Inc Anebulo Pharmaceuticals, Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Anebulo Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 153,472 shares of ANEB stock, worth $382,145. This represents 0.0% of its overall portfolio holdings.
Number of Shares
153,472
Previous 153,003
0.31%
Holding current value
$382,145
Previous $370,000
18.92%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ANEB
# of Institutions
16Shares Held
7.31MCall Options Held
0Put Options Held
0-
22 Nw, LP Seattle, WA5.37MShares$13.4 Million15.16% of portfolio
-
Lvw Advisors, LLC642KShares$1.6 Million0.32% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT511KShares$1.27 Million0.09% of portfolio
-
Morgan Stanley New York, NY399KShares$994,0550.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX158KShares$393,0760.06% of portfolio
About Anebulo Pharmaceuticals, Inc.
- Ticker ANEB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,633,200
- Market Cap $63.8M
- Description
- Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The ...